{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:27:04Z","timestamp":1754112424278},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:00:00Z","timestamp":1496016000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00059-017-4578-x","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T11:46:07Z","timestamp":1496058367000},"page":"449-458","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Angeborene St\u00f6rungen im Lipoproteinstoffwechsel"],"prefix":"10.1007","volume":"42","author":[{"given":"W.","family":"M\u00e4rz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. B.","family":"Grammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Kleber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"key":"4578_CR1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel M, Varret M, Rabes JP et\u00a0al (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34:154\u2013156","journal-title":"Nat Genet"},{"key":"4578_CR2","first-page":"492","volume":"38","author":"TH Beaty","year":"1986","unstructured":"Beaty TH, Kwiterovich PO Jr., Khoury MJ et\u00a0al (1986) Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a\u00a0large Amish pedigree with sitosterolemia. Am J Hum Genet 38:492\u2013504","journal-title":"Am J Hum Genet"},{"key":"4578_CR3","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","volume":"97","author":"M Benn","year":"2012","unstructured":"Benn M, Watts GF, Tybjaerg-Hansen A et al (2012) Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J\u00a0Clin Endocrinol Metab 97:3956\u20133964","journal-title":"J Clin Endocrinol Metab"},{"key":"4578_CR4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","volume":"290","author":"KE Berge","year":"2000","unstructured":"Berge KE, Tian H, Graf GA et\u00a0al (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771\u20131775","journal-title":"Science"},{"key":"4578_CR5","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1194\/jlr.R006338","volume":"51","author":"I Bjorkhem","year":"2010","unstructured":"Bjorkhem I, Leoni V, Meaney S (2010) Genetic connections between neurological disorders and cholesterol metabolism. J\u00a0Lipid Res 51:2489\u20132503","journal-title":"J Lipid Res"},{"key":"4578_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","volume":"22","author":"M Bodzioch","year":"1999","unstructured":"Bodzioch M, Orso E, Klucken J et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347\u2013351","journal-title":"Nat Genet"},{"key":"4578_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ejhg.2015.100","volume":"24","author":"I Braenne","year":"2016","unstructured":"Braenne I, Kleinecke M, Reiz B et\u00a0al (2016) Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction. Eur J Hum Genet 24:191\u2013197","journal-title":"Eur J Hum Genet"},{"key":"4578_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MOL.0000000000000270","volume":"27","author":"AJ Brahm","year":"2016","unstructured":"Brahm AJ, Hegele RA (2016) Combined hyperlipidemia: familial but not (usually) monogenic. Curr Opin Lipidol 27:131\u2013140","journal-title":"Curr Opin Lipidol"},{"key":"4578_CR9","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT et al (2016) The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J\u00a0Clin Endocrinol Metab 101:4500\u20134511","journal-title":"J Clin Endocrinol Metab"},{"key":"4578_CR10","unstructured":"Bundesausschuss G (2016) Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie (AM-RL): Anlage III \u2013 \u00dcbersicht \u00fcber Verordnungseinschr\u00e4nkungen und -ausschl\u00fcsse Alirocumab. 4. August 2016"},{"key":"4578_CR11","unstructured":"Bundesausschuss G (2016) Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie (AM-RL): Anlage III \u2013 \u00dcbersicht \u00fcber Verordnungseinschr\u00e4nkungen und -ausschl\u00fcsse Evolocumab. BAnz AT 12. Aug. 2016 B1"},{"key":"4578_CR12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","volume":"120","author":"L Calabresi","year":"2009","unstructured":"Calabresi L, Baldassarre D, Castelnuovo S et\u00a0al (2009) Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120:628\u2013635","journal-title":"Circulation"},{"key":"4578_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G et\u00a0al (2016) 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 253:281\u2013344","journal-title":"Atherosclerosis"},{"key":"4578_CR14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","volume":"102","author":"F Civeira","year":"2008","unstructured":"Civeira F, Ros E, Jarauta E et\u00a0al (2008) Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol 102:1187\u20131193.e1","journal-title":"Am J Cardiol"},{"key":"4578_CR15","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC et\u00a0al (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N\u00a0Engl J Med 361:2518\u20132528","journal-title":"N Engl J Med"},{"key":"4578_CR16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley TH et\u00a0al (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N\u00a0Engl J Med 354:1264\u20131272","journal-title":"N Engl J Med"},{"key":"4578_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","volume":"180","author":"D Damgaard","year":"2005","unstructured":"Damgaard D, Larsen ML, Nissen PH et\u00a0al (2005) The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a\u00a0Danish population. Atherosclerosis 180:155\u2013160","journal-title":"Atherosclerosis"},{"key":"4578_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry PL et\u00a0al (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412\u2013423","journal-title":"JAMA"},{"key":"4578_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<417::AID-HUMU1>3.0.CO;2-5","volume":"11","author":"G Feussner","year":"1998","unstructured":"Feussner G, Feussner V, Hoffmann MM et\u00a0al (1998) Molecular basis of type III hyperlipoproteinemia in Germany. Hum Mutat 11:417\u2013423","journal-title":"Hum Mutat"},{"key":"4578_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"4578_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","volume":"51","author":"M Futema","year":"2014","unstructured":"Futema M, Plagnol V, Li K et\u00a0al (2014) Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations. J\u00a0Med Genet 51:537\u2013544","journal-title":"J Med Genet"},{"key":"4578_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","volume":"61","author":"M Futema","year":"2015","unstructured":"Futema M, Shah S, Cooper JA et\u00a0al (2015) Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries. Clin Chem 61:231\u2013238","journal-title":"Clin Chem"},{"key":"4578_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","volume":"229","author":"M Futema","year":"2013","unstructured":"Futema M, Whittall RA, Kiley A et\u00a0al (2013) Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a\u00a0UK specialist hospital lipid clinic. Atherosclerosis 229:161\u2013168","journal-title":"Atherosclerosis"},{"key":"4578_CR24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","volume":"27","author":"GN Gallus","year":"2006","unstructured":"Gallus GN, Dotti MT, Federico A (2006) Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a\u00a0review of the mutations in the CYP27A1 gene. Neurol Sci 27:143\u2013149","journal-title":"Neurol Sci"},{"key":"4578_CR25","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","volume":"292","author":"CK Garcia","year":"2001","unstructured":"Garcia CK, Wilund K, Arca M et\u00a0al (2001) Autosomal recessive hypercholesterolemia caused by mutations in a\u00a0putative LDL receptor adaptor protein. Science 292:1394\u20131398","journal-title":"Science"},{"key":"4578_CR26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurheartj\/ehr441","volume":"33","author":"B Genser","year":"2012","unstructured":"Genser B, Silbernagel G, De Backer G et al (2012) Plant sterols and cardiovascular disease: a\u00a0systematic review and meta-analysis. Eur Heart\u00a0J 33:444\u2013451","journal-title":"Eur Heart J"},{"key":"4578_CR27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.atherosclerosis.2016.08.037","volume":"253","author":"T Grenkowitz","year":"2016","unstructured":"Grenkowitz T, Kassner U, Wuhle-Demuth M et al (2016) Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia. Atherosclerosis 253:88\u201393","journal-title":"Atherosclerosis"},{"key":"4578_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOL.0000000000000163","volume":"26","author":"RA Hegele","year":"2015","unstructured":"Hegele RA, Ban MR, Cao H et al (2015) Targeted next-generation sequencing in monogenic dyslipidemias. Curr Opin Lipidol 26:103\u2013113","journal-title":"Curr Opin Lipidol"},{"key":"4578_CR29","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/hmg\/ddp361","volume":"18","author":"RA Hegele","year":"2009","unstructured":"Hegele RA, Ban MR, Hsueh N et\u00a0al (2009) A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Hum Mol Genet 18:4189\u20134194","journal-title":"Hum Mol Genet"},{"key":"4578_CR30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","volume":"2","author":"RA Hegele","year":"2014","unstructured":"Hegele RA, Ginsberg HN, Chapman MJ et\u00a0al (2014) The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol 2:655\u2013666","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4578_CR31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2004.06.070","volume":"44","author":"GK Hovingh","year":"2004","unstructured":"Hovingh GK, Brownlie A, Bisoendial RJ et al (2004) A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J\u00a0Am Coll Cardiol 44:1429\u20131435","journal-title":"J Am Coll Cardiol"},{"key":"4578_CR32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jmg.2006.038356","volume":"43","author":"SE Humphries","year":"2006","unstructured":"Humphries SE, Whittall RA, Hubbart CS et\u00a0al (2006) Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J\u00a0Med Genet 43:943\u2013949","journal-title":"J Med Genet"},{"key":"4578_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","volume":"55","author":"CT Johansen","year":"2014","unstructured":"Johansen CT, Dube JB, Loyzer MN et al (2014) LipidSeq: a\u00a0next-generation clinical resequencing panel for monogenic dyslipidemias. J\u00a0Lipid Res 55:765\u2013772","journal-title":"J Lipid Res"},{"key":"4578_CR34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","volume":"22","author":"CT Johansen","year":"2011","unstructured":"Johansen CT, Hegele RA (2011) Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol 22:247\u2013253","journal-title":"Curr Opin Lipidol"},{"key":"4578_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng1145","volume":"34","author":"B Jones","year":"2003","unstructured":"Jones B, Jones EL, Bonney SA et\u00a0al (2003) Mutations in a\u00a0Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 34:29\u201331","journal-title":"Nat. Genet."},{"key":"4578_CR36","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","volume":"67","author":"AV Khera","year":"2016","unstructured":"Khera AV, Won HH, Peloso GM et\u00a0al (2016) Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J\u00a0Am Coll Cardiol 67:2578\u20132589","journal-title":"J Am Coll Cardiol"},{"key":"4578_CR37","first-page":"523","volume":"111","author":"G Klose","year":"2014","unstructured":"Klose G, Laufs U, M\u00e4rz W et\u00a0al (2014) Familial hypercholesterolemia: developments in diagnosis and treatment. Dtsch Arztebl Int 111:523\u2013529","journal-title":"Dtsch Arztebl Int"},{"key":"4578_CR38","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1093\/eurheartj\/eht053","volume":"34","author":"KM Kostner","year":"2013","unstructured":"Kostner KM, M\u00e4rz W, Kostner GM (2013) When should we measure lipoprotein (a)? Eur Heart\u00a0J 34:3268\u20133276","journal-title":"Eur Heart J"},{"key":"4578_CR39","first-page":"748","volume":"112","author":"U Laufs","year":"2015","unstructured":"Laufs U, Scharnagl H, Halle M et al (2015) Treatment options for statin-associated muscle symptoms. Dtsch Arztebl Int 112:748\u2013755","journal-title":"Dtsch Arztebl Int"},{"key":"4578_CR40","first-page":"26","volume":"11","author":"TP Leren","year":"2008","unstructured":"Leren TP, Finborud TH, Manshaus TE et\u00a0al (2008) Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Community Genet 11:26\u201335","journal-title":"Community Genet"},{"key":"4578_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/er.2014-1062","volume":"36","author":"GF Lewis","year":"2015","unstructured":"Lewis GF, Xiao C, Hegele RA (2015) Hypertriglyceridemia in the genomic era: a\u00a0new paradigm. Endocr Rev 36:131\u2013147","journal-title":"Endocr Rev"},{"key":"4578_CR42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"E Link","year":"2008","unstructured":"Link E, Parish S, Armitage J et al (2008) SLCO1B1 variants and statin-induced myopathy \u2013 a genomewide study. N\u00a0Engl J Med 359:789\u2013799","journal-title":"N Engl J Med"},{"key":"4578_CR43","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbalip.2015.09.006","volume":"1851","author":"SA Ljunggren","year":"2015","unstructured":"Ljunggren SA, Levels JH, Hovingh K et\u00a0al (2015) Lipoprotein profiles in human heterozygote carriers of a\u00a0functional mutation P297S in scavenger receptor class B1. Biochim Biophys Acta 1851:1587\u20131595","journal-title":"Biochim. Biophys. Acta"},{"key":"4578_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","volume":"168","author":"D Marks","year":"2003","unstructured":"Marks D, Thorogood M, Neil HA et\u00a0al (2003) A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 168:1\u201314","journal-title":"Atherosclerosis"},{"key":"4578_CR45","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1172\/JCI116915","volume":"92","author":"W M\u00e4rz","year":"1993","unstructured":"M\u00e4rz W, Baumstark MW, Scharnagl H et al (1993) Accumulation of \u2018small dense\u2019 low density lipoproteins in a\u00a0homozygous patient with familial defective apolipoprotein B\u2011100 results from heterogenous interaction of LDL-subfractions with the LDL receptor. J\u00a0Clin Invest 92:2922\u20132933","journal-title":"J Clin Invest"},{"issue":"1","key":"4578_CR46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00059-016-4499-0","volume":"42","author":"W M\u00e4rz","year":"2017","unstructured":"M\u00e4rz W, Kleber ME, Scharnagl H et\u00a0al (2017) Clinical importance of HDL cholesterol. Herz 42(1):58\u201366","journal-title":"Herz"},{"key":"4578_CR47","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/0140-6736(92)92554-S","volume":"340","author":"W M\u00e4rz","year":"1992","unstructured":"M\u00e4rz W, Ruzicka V, Pohl T et al (1992) Familial defective apolipoprotein B\u2011100: mild hypercholesterolemia without atherosclerosis in a\u00a0homozygous patient. Lancet 340:1362","journal-title":"Lancet"},{"key":"4578_CR48","first-page":"13","volume":"2016","author":"W M\u00e4rz","year":"2016","unstructured":"M\u00e4rz W, Scharnagl H, Laufs U (2016) Statin-assoziierte Muskelbeschwerden: Mythos oder Wirklichkeit? Herzmedizin 2016:13\u201319","journal-title":"Herzmedizin"},{"key":"4578_CR49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10545-015-9873-1","volume":"39","author":"A Mignarri","year":"2016","unstructured":"Mignarri A, Magni A, Del Puppo M et\u00a0al (2016) Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis. J\u00a0Inherit Metab Dis 39:75\u201383","journal-title":"J Inherit Metab Dis"},{"key":"4578_CR50","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehm066","volume":"28","author":"KM Modesto","year":"2007","unstructured":"Modesto KM, Dispenzieri A, Gertz M et\u00a0al (2007) Vascular abnormalities in primary amyloidosis. Eur Heart\u00a0J 28:1019\u20131024","journal-title":"Eur Heart J"},{"key":"4578_CR51","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","volume":"363","author":"K Musunuru","year":"2010","unstructured":"Musunuru K, Pirruccello JP, Do R et\u00a0al (2010) Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N\u00a0Engl J Med 363:2220\u20132227","journal-title":"N Engl J Med"},{"key":"4578_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.1171","volume":"18","author":"MS Nauck","year":"2001","unstructured":"Nauck MS, K\u00f6ster W, D\u00f6rfer K et\u00a0al (2001) Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia. Hum Mutat 18:165\u2013166","journal-title":"Hum Mutat"},{"key":"4578_CR53","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/clinchem\/44.7.1388","volume":"44","author":"MS Nauck","year":"1998","unstructured":"Nauck MS, Nissen H, Hoffmann MM et al (1998) Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a\u00a0patient with severe hypertriglyceridemia. Clin Chem 44:1388\u20131396","journal-title":"Clin Chem"},{"key":"4578_CR54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0021-9150(99)00415-3","volume":"151","author":"MS Nauck","year":"2000","unstructured":"Nauck MS, Scharnagl H, Nissen H et al (2000) FH-Freiburg: a\u00a0novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a\u00a0German patient with homozygous familial hypercholesterolemia. Atherosclerosis 151:525\u2013534","journal-title":"Atherosclerosis"},{"key":"4578_CR55","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K et\u00a0al (2010) Lipoprotein(a) as a\u00a0cardiovascular risk factor: current status. Eur Heart\u00a0J 31:2844\u20132853","journal-title":"Eur Heart J"},{"key":"4578_CR56","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.fpc.0000230416.82349.90","volume":"16","author":"MK Pasanen","year":"2006","unstructured":"Pasanen MK, Neuvonen M, Neuvonen PJ et\u00a0al (2006) SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenet Genomics 16:873\u2013879","journal-title":"Pharmacogenet Genomics"},{"key":"4578_CR57","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S et\u00a0al (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart\u00a0J 37:2315\u20132381","journal-title":"Eur Heart J"},{"key":"4578_CR58","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00508-006-0718-7","volume":"118","author":"C Putz-Bankuti","year":"2006","unstructured":"Putz-Bankuti C, Datz C, M\u00e4rz W et al (2006) Clinical-pathological conference series from the Medical University of Graz : case no. 131: elevated transaminases in a\u00a030-year-old male. Wien Klin Wochenschr 118:769\u2013775","journal-title":"Wien Klin Wochenschr"},{"key":"4578_CR59","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Z Reiner","year":"2011","unstructured":"Reiner Z, Catapano AL, De Backer G et\u00a0al (2011) ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart\u00a0J 32:1769\u20131818","journal-title":"Eur Heart J"},{"key":"4578_CR60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","volume":"235","author":"Z Reiner","year":"2014","unstructured":"Reiner Z, Guardamagna O, Nair D et al (2014) Lysosomal acid lipase deficiency \u2013 an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis 235:21\u201330","journal-title":"Atherosclerosis"},{"key":"4578_CR61","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.109.875013","volume":"121","author":"A Ritsch","year":"2010","unstructured":"Ritsch A, Scharnagl H, Eller P et\u00a0al (2010) Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 121:366\u2013374","journal-title":"Circulation"},{"key":"4578_CR62","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","volume":"22","author":"S Rust","year":"1999","unstructured":"Rust S, Rosier M, Funke H et al (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352\u2013355","journal-title":"Nat Genet"},{"key":"4578_CR63","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/ajmg.a.34040","volume":"155A","author":"CP Schaaf","year":"2011","unstructured":"Schaaf CP, Koster J, Katsonis P et al (2011) Desmosterolosis-phenotypic and molecular characterization of a\u00a0third case and review of the literature. Am J Med Genet\u00a0A 155A:1597\u20131604","journal-title":"Am J Med Genet A"},{"key":"4578_CR64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOL.0b013e32833c1ef6","volume":"21","author":"EJ Schaefer","year":"2010","unstructured":"Schaefer EJ, Santos RD, Asztalos BF (2010) Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol 21:289\u2013297","journal-title":"Curr Opin Lipidol"},{"key":"4578_CR65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2013.01.100","volume":"62","author":"G Silbernagel","year":"2013","unstructured":"Silbernagel G, Chapman MJ, Genser B et al (2013) High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a\u00a0meta-analysis. J\u00a0Am Coll Cardiol 62:291\u2013299","journal-title":"J Am Coll Cardiol"},{"key":"4578_CR66","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1194\/jlr.P002899","volume":"51","author":"G Silbernagel","year":"2010","unstructured":"Silbernagel G, Fauler G, Hoffmann MM et al (2010) The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J\u00a0Lipid Res 51:2384\u20132393","journal-title":"J Lipid Res"},{"key":"4578_CR67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1194\/jlr.P800013-JLR200","volume":"50","author":"G Silbernagel","year":"2009","unstructured":"Silbernagel G, Fauler G, Renner W et\u00a0al (2009) The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J\u00a0Lipid Res 50:334\u2013341","journal-title":"J Lipid Res"},{"key":"4578_CR68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","volume":"4","author":"AK Soutar","year":"2007","unstructured":"Soutar AK, Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4:214\u2013225","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"4578_CR69","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","volume":"374","author":"NO Stitziel","year":"2016","unstructured":"Stitziel NO, Stirrups KE, Masca NG et\u00a0al (2016) Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N\u00a0Engl J Med 374:1134\u20131144","journal-title":"N Engl J Med"},{"key":"4578_CR70","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A et al (2015) Statin-associated muscle symptoms: impact on statin therapy \u2013 European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart\u00a0J 36:1012\u20131022","journal-title":"Eur Heart J"},{"key":"4578_CR71","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOL.0000000000000090","volume":"25","author":"PJ Talmud","year":"2014","unstructured":"Talmud PJ, Futema M, Humphries SE (2014) The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes. Curr Opin Lipidol 25:274\u2013281","journal-title":"Curr Opin Lipidol"},{"key":"4578_CR72","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","volume":"381","author":"PJ Talmud","year":"2013","unstructured":"Talmud PJ, Shah S, Whittall R et al (2013) Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a\u00a0case-control study. Lancet 381:1293\u20131301","journal-title":"Lancet"},{"key":"4578_CR73","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","volume":"77","author":"A Taylor","year":"2010","unstructured":"Taylor A, Wang D, Patel K et\u00a0al (2010) Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet 77:572\u2013580","journal-title":"Clin Genet"},{"key":"4578_CR74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCGENETICS.109.907873","volume":"3","author":"D Teupser","year":"2010","unstructured":"Teupser D, Baber R, Ceglarek U et\u00a0al (2010) Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 3:331\u2013339","journal-title":"Circ Cardiovasc Genet"},{"key":"4578_CR75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.163.1.65","volume":"163","author":"MA Umans-Eckenhausen","year":"2003","unstructured":"Umans-Eckenhausen MA, Defesche JC, Van Dam MJ et al (2003) Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. Arch Intern Med 163:65\u201368","journal-title":"Arch Intern Med"},{"key":"4578_CR76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","volume":"364","author":"M Vergeer","year":"2011","unstructured":"Vergeer M, Korporaal SJ, Franssen R et\u00a0al (2011) Genetic variant of the scavenger receptor BI in humans. N\u00a0Engl J Med 364:136\u2013145","journal-title":"N Engl J Med"},{"key":"4578_CR77","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","volume":"337","author":"J Versmissen","year":"2008","unstructured":"Versmissen J, Oosterveer DM, Yazdanpanah M et\u00a0al (2008) Efficacy of statins in familial hypercholesterolaemia: a\u00a0long term cohort study. BMJ 337:a2423","journal-title":"BMJ"},{"key":"4578_CR78","first-page":"202","volume":"49","author":"EP Walma","year":"2006","unstructured":"Walma EP, Wiersma TJ (2006) NHG-Standpunt Diagnostiek en behandeling van familiaire hypercholesterolemie. Huisarts Wet 49:202\u2013204","journal-title":"Huisarts Wet"},{"key":"4578_CR79","first-page":"212","volume":"20","author":"A Wierzbicka-Rucinska","year":"2016","unstructured":"Wierzbicka-Rucinska A, Janczyk W, Lugowska A et al (2016) Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D). Review of the literature and own experience. Dev Period Med 20:212\u2013215","journal-title":"Dev Period Med"},{"key":"4578_CR80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCGENETICS.110.958728","volume":"4","author":"PS Wild","year":"2011","unstructured":"Wild PS, Zeller T, Schillert A et al (2011) A genome-wide association study identifies LIPA as a\u00a0susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 4:403\u2013412","journal-title":"Circ Cardiovasc Genet"},{"key":"4578_CR81","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1194\/jlr.R018689","volume":"52","author":"SG Young","year":"2011","unstructured":"Young SG, Davies BS, Voss CV et\u00a0al (2011) GPIHBP1, an endothelial cell transporter for lipoprotein lipase. J\u00a0Lipid Res 52:1869\u20131884","journal-title":"J Lipid Res"},{"key":"4578_CR82","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","volume":"351","author":"P Zanoni","year":"2016","unstructured":"Zanoni P, Khetarpal SA, Larach DB et\u00a0al (2016) Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 351:1166\u20131171","journal-title":"Science"},{"key":"4578_CR83","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","volume":"79","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Tuakli-Wosornu Y, Lagace TA et al (2006) Molecular characterization of loss-of-function mutations in PCSK9 and identification of a\u00a0compound heterozygote. Am J Hum Genet 79:514\u2013523","journal-title":"Am J Hum Genet"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-017-4578-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T20:46:46Z","timestamp":1602190006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-017-4578-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,29]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4578"],"URL":"https:\/\/doi.org\/10.1007\/s00059-017-4578-x","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,29]]}}}